Logue, Susan E <br/><br/>
Inhibition of IRE1 RNase activity modulates the tumor cell secretome and enhances response to chemotherapy.  [electronic resource] 

 -  Nature communications  08 2018 
 - 3267 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2041-1723 
<br/><br/><label>Standard No.: </label>10.1038/s41467-018-05763-8  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Combined Chemotherapy Protocols--pharmacology<br/>Cell Line<br/>Cell Line, Tumor<br/>Endoribonucleases--antagonists & inhibitors<br/>Enzyme Inhibitors--administration & dosage<br/>Female<br/>Gene Expression Profiling<br/>Gene Expression Regulation, Neoplastic<br/>HEK293 Cells<br/>Humans<br/>Mice, Nude<br/>Paclitaxel--administration & dosage<br/>Protein Serine-Threonine Kinases--antagonists & inhibitors<br/>RNA Interference<br/>Triple Negative Breast Neoplasms--drug therapy<br/>Xenograft Model Antitumor Assays